The Technical Advisory Group (TAG) on October 26 had sought additional clarifications from the company for Covaxin to conduct a final risk-benefit assessment for Emergency Use Listing of the vaccine.
World Health Organisation Director-General Tedros Adhanom Ghebreyesus on Wednesday said he is "glad" to see Covaxin get the Emergency Use Listing approval.